These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 29599777)

  • 1. Tissue Destruction in Bullous Pemphigoid Can Be Complement Independent and May Be Mitigated by C5aR2.
    Karsten CM; Beckmann T; Holtsche MM; Tillmann J; Tofern S; Schulze FS; Heppe EN; Ludwig RJ; Zillikens D; König IR; Köhl J; Schmidt E
    Front Immunol; 2018; 9():488. PubMed ID: 29599777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of C5aR1 and C5aR2 in innate and adaptive immune cells located in early skin lesions of bullous pemphigoid patients.
    Emtenani S; Holtsche MM; Stahlkopf R; Seiler DL; Burn T; Liu H; Parker M; Yilmaz K; Dikmen HO; Lang MH; Sadik CD; Karsten CM; van Beek N; Ludwig RJ; Köhl J; Schmidt E
    Front Immunol; 2022; 13():942493. PubMed ID: 36466856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bullous pemphigoid autoantibodies directly induce blister formation without complement activation.
    Ujiie H; Sasaoka T; Izumi K; Nishie W; Shinkuma S; Natsuga K; Nakamura H; Shibaki A; Shimizu H
    J Immunol; 2014 Nov; 193(9):4415-28. PubMed ID: 25261486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to pathogenic epitopes on type XVII collagen cause skin fragility in a complement-dependent and -independent manner.
    Natsuga K; Nishie W; Shinkuma S; Ujiie H; Nishimura M; Sawamura D; Shimizu H
    J Immunol; 2012 Jun; 188(11):5792-9. PubMed ID: 22523387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen.
    Ujiie H; Shibaki A; Nishie W; Sawamura D; Wang G; Tateishi Y; Li Q; Moriuchi R; Qiao H; Nakamura H; Akiyama M; Shimizu H
    J Immunol; 2010 Feb; 184(4):2166-74. PubMed ID: 20089696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII.
    Nishie W
    J Dermatol Sci; 2014 Mar; 73(3):179-86. PubMed ID: 24434029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-collagen XVII single-chain Fv antibody blocks the autoimmune reaction mediated by pathogenic autoantibodies in bullous pemphigoid.
    Wu Y; Sun NN; Dang EL; Jin L; Liu ZF; Zhang W; Yang LT; Wang G
    J Dermatol Sci; 2013 Oct; 72(1):25-31. PubMed ID: 23827201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bullous pemphigoid induced by IgG targeting type XVII collagen non-NC16A/NC15A extracellular domains is driven by Fc gamma receptor- and complement-mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade.
    Pigors M; Patzelt S; Reichhelm N; Dworschak J; Khil'chenko S; Emtenani S; Bieber K; Hofrichter M; Kamaguchi M; Goletz S; Köhl G; Köhl J; Komorowski L; Probst C; Vanderheyden K; Balbino B; Ludwig RJ; Verheesen P; Schmidt E
    J Pathol; 2024 Feb; 262(2):161-174. PubMed ID: 37929639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning of hamster type XVII collagen cDNA, and pathogenesis of anti-type XVII collagen antibody and complement in hamster bullous pemphigoid.
    Yamamoto K; Inoue N; Masuda R; Fujimori A; Saito T; Imajoh-Ohmi S; Shinkai H; Sakiyama H
    J Invest Dermatol; 2002 Mar; 118(3):485-92. PubMed ID: 11874488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fcγ receptors III and IV mediate tissue destruction in a novel adult mouse model of bullous pemphigoid.
    Schulze FS; Beckmann T; Nimmerjahn F; Ishiko A; Collin M; Köhl J; Goletz S; Zillikens D; Ludwig R; Schmidt E
    Am J Pathol; 2014 Aug; 184(8):2185-96. PubMed ID: 25043618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Expression of Collagen XVII Compensates for its Depletion Induced by Pemphigoid IgG in the Oral Mucosa.
    Kamaguchi M; Iwata H; Ujiie H; Natsuga K; Nishie W; Kitagawa Y; Shimizu H
    J Invest Dermatol; 2018 Aug; 138(8):1707-1715. PubMed ID: 29530535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repetitive immunization breaks tolerance to type XVII collagen and leads to bullous pemphigoid in mice.
    Hirose M; Recke A; Beckmann T; Shimizu A; Ishiko A; Bieber K; Westermann J; Zillikens D; Schmidt E; Ludwig RJ
    J Immunol; 2011 Aug; 187(3):1176-83. PubMed ID: 21705619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgE autoantibodies in bullous pemphigoid: supporting role, or leading player?
    Ujiie H
    J Dermatol Sci; 2015 Apr; 78(1):5-10. PubMed ID: 25797172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Reaction to Type XVII Collagen Induces Intramolecular and Intermolecular Epitope Spreading in Experimental Bullous Pemphigoid Models.
    Ujiie H; Yoshimoto N; Natsuga K; Muramatsu K; Iwata H; Nishie W; Shimizu H
    Front Immunol; 2019; 10():1410. PubMed ID: 31275329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of complement in experimental bullous pemphigoid.
    Liu Z; Giudice GJ; Swartz SJ; Fairley JA; Till GO; Troy JL; Diaz LA
    J Clin Invest; 1995 Apr; 95(4):1539-44. PubMed ID: 7706459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What's new in bullous pemphigoid.
    Ujiie H; Shibaki A; Nishie W; Shimizu H
    J Dermatol; 2010 Mar; 37(3):194-204. PubMed ID: 20507382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noncollagenous 16A domain of type XVII collagen-reactive CD4+ T cells play a pivotal role in the development of active disease in experimental bullous pemphigoid model.
    Ujiie H; Shibaki A; Nishie W; Shinkuma S; Moriuchi R; Qiao H; Shimizu H
    Clin Immunol; 2012 Feb; 142(2):167-75. PubMed ID: 22044750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human IgG1 monoclonal antibody against human collagen 17 noncollagenous 16A domain induces blisters via complement activation in experimental bullous pemphigoid model.
    Li Q; Ujiie H; Shibaki A; Wang G; Moriuchi R; Qiao HJ; Morioka H; Shinkuma S; Natsuga K; Long HA; Nishie W; Shimizu H
    J Immunol; 2010 Dec; 185(12):7746-55. PubMed ID: 21076071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of bullous pemphigoid.
    Ujiie H; Nishie W; Shimizu H
    Immunol Allergy Clin North Am; 2012 May; 32(2):207-15, v. PubMed ID: 22560134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The critical role of C5a as an initiator of neutrophil-mediated autoimmune inflammation of the joint and skin.
    Sadik CD; Miyabe Y; Sezin T; Luster AD
    Semin Immunol; 2018 Jun; 37():21-29. PubMed ID: 29602515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.